AFMD - Affimed N.V.
0.685
-0.015 -2.190%
Share volume: 93,525
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.70
-0.01
-0.02%
Summary score
33%
Profitability
25%
Dept financing
17%
Liquidity
75%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-22.12%
Return on assets
-12.52%
Return on sales
0%
Return on invested capital
301.82%
Total debt ratio
39.91%
Debt ratio change over timeo
0%
Current Ratio
5%
Quick Ratio
4.97%
Cash Position Ratio
4.2%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-34.85%
Return on assets
-11.48%
Return on sales
0%
Return on invested capital
41.75%
Total debt ratio
66.85%
Debt ratio change over timeo
0%
Current Ratio
2.81%
Quick Ratio
2.8%
Cash Position Ratio
2.43%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-29.63%
Return on assets
-11.02%
Return on sales
0%
Return on invested capital
45.43%
Total debt ratio
59.96%
Debt ratio change over time
0%
Current Ratio
2.93%
Quick Ratio
2.91%
Cash Position Ratio
2.6%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AFMD | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -22.12% | 17.45% | 4.69% | 19.89% |
| Return on assets | -12.52% | 3.37% | 3.35% | 11.41% |
| Return on sales | 0% | 23.96% | 25.96% | 42.05% |
| Return on invested capital | 301.82% | 5.2% | 4.37% | -272.99% |
| Profitability | 25% | 44% | 29% | 75% |
| Total debt ratio | 39.91% | 77% | 57.66% | 53.92% |
| Debt ratio change over time | 0% | 0% | 10.55% | 0% |
| Dept financing | 13% | 25% | 44% | 18% |
| Current Ratio | 2.81% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 2.8% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 2.43% | 0.17% | 0.53% | 0.31% |
| Liquididy | 75% | 14% | 18% | 12% |
| Short-term ratios | AFMD | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -34.85% | 44.06% | 6.24% | 17.3% |
| Return on assets | -11.48% | 3.88% | 3.22% | 9.33% |
| Return on sales | 0% | 27.04% | 24.93% | 40.02% |
| Return on invested capital | 41.75% | 9.69% | 4.96% | -224.06% |
| Profitability | 25% | 58% | 31% | 60% |
| Total debt ratio | 66.85% | 91.8% | 61.39% | 55.88% |
| Debt ratio change over time | 0% | 0% | 12.93% | 0% |
| Dept financing | 18% | 25% | 42% | 15% |
| Current Ratio | 2.81% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 2.8% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 2.43% | 0.17% | 0.53% | 0.31% |
| Liquididy | 75% | 20% | 26% | 19% |
